Sigh... Black and white...Not. Multiple shades of grey.
To be honest. There are multiple proofs that Bavi works.
A deal is probably really difficult to ink because BP will want an exclusive right on the molecule. PPHM may want to have a war bid... But PPHM is still vulnerable financially.
That's why Avid is so important. Because they have no P3 running, the expense must have been lowered. Enough to black ink next ERs.
Burn rate is reduced. More than 40 millions in the piggy.
October 10th will be decisive. I think we will get back to 2012 level (outstanding shares number adjusted)
Then we will get an FDA approval opening the gates.
Mind puzzling is why keep this low-40s? For the benefit of?